Biotechnology

Edesa Biotech to Host Key Opinion Leader Webinar on EB05 for the Treatment of Acute Respiratory Distress Syndrome

April 22, 2021 8:00 AM

Virtual event scheduled for Thursday, April 29 at 1 pm Eastern Time TORONTO, ON / ACCESSWIRE / April 22, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, announced today that it will host a key opinion leader (KOL) webinar on EB05, the company's lead asset for the treatment of Acute Respiratory Distress Syndrome (ARDS), on Thursday, April 29, 2021 at 1:00...

Read more

Lexaria Commences Human Clinical Hypertension Study

April 22, 2021 7:00 AM

Study to examine DehydraTECHTM CBD's ability to control blood pressure First of three human clinical studies hoped to validate Lexaria's patented technology for hypertension relief KELOWNA, BC / ACCESSWIRE / April 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that its human clinical hypertension study HYPER-H21-1 is...

Read more

HMNC Brain Health Embarks on Next Phase of Growth with New Leadership Team

April 22, 2021 4:50 AM

Benedikt von Braunmühl named new CEO Dr. Hans Eriksson appointed Chief Clinical Development Officer Dr. Franz Humer strengthens Board of Directors as Chairman Founder Prof. Dr. Dr. Dr. h.c. mult. Florian Holsboer to lead Scientific Advisory Board MUNICH, GERMANY / ACCESSWIRE / April 22, 2021 / HMNC Brain Health, a biotech company focused on the development of innovative and personalized treatments for depression and other...

Read more

Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System

April 21, 2021 4:15 PM

Authors conclude, "Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation." AUSTIN, TX / ACCESSWIRE / April 21, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the publication of supporting pre-clinical results for the X-Tack™ Endoscopic...

Read more

Oncology Pharma, Inc. Prepares Plan Toward Funding Development and Implementation of Ribera Solutions' Patient Engagement and Retention Platform

April 21, 2021 10:00 AM

SAN FRANCISCO, CA / ACCESSWIRE / April 21, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc. (the "Company") is moving ahead with advancing its efforts with Ribera Solutions' Conect2Med platform with Oncology Pharma's exclusivity for oncology, including drug development, clinical trials, personalized oncology and therapeutics. Ribera has been developing its platform and Oncology Pharma, under its License Agreement, is preparing...

Read more

Shareholders of Molecular Partners AG Approve all Board Proposals at the Annual General Meeting; Agnete Fredriksen and Dominik Höchli Elected New Board Members

April 21, 2021 9:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / April 21, 2021 / At today's AGM of Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, the shareholders of the company approved all motions proposed by the Board of Directors with a very large majority. In light of the current COVID-19 situation and in line with the applicable Swiss regulation, this...

Read more

MJ Biotech Partner Genesis Botanical Signs An Additional Three Hemp Farmers, Securing 115 Additional acres of Hemp Biomass for CBD Extraction

April 21, 2021 7:30 AM

CHEYENNE, WY / ACCESSWIRE / April 21, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report its CBD Extraction partner, Genesis Botanical Research (GBR), has secured another 115 acres of hemp biomass to extract bringing the total amount to 155 acres with the 40 acres previously secured. GBR has contacted and had communications with less than 15% of the entire list of licensed hemp growers in the state of Maine. More contracts are...

Read more

Wuhan General Group Recruiting in Lesotho for its Medicinal Cannabis Cultivation Facility

April 20, 2021 10:00 AM

CAPE TOWN, SA / ACCESSWIRE / April 20, 2021 / WUHAN GENERAL GROUP, INC. (WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to announce on the occasion of ‘420 Day' or ‘Weed Day' that the company, through its local subsidiary, Tsime Pharmaceuticals and Medicinal Supplies, has started recruiting its team for the rollout of a world class medicinal...

Read more

MorphoSys and Incyte Announce First Patient Dosed in Phase 3 inMIND Study Evaluating the Addition of Tafasitamab to Lenalidomide and Rituximab in Relapsed or Refractory Follicular or Marginal Zone Lymphoma

April 19, 2021 4:01 PM

PLANEGG/MUNICH, GERMANY and WILMINGTON, DE / ACCESSWIRE / April 19, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR) and Incyte (NASDAQ:INCY) today announced the first patient has been dosed in the placebo-controlled Phase 3 inMIND study evaluating the efficacy and safety of tafasitamab or placebo in combination with lenalidomide and rituximab in patients with relapsed or refractory follicular lymphoma (FL) or...

Read more

Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2020 Financial Results and Provide Business Update

April 19, 2021 3:00 PM

Conference Call Scheduled for Wednesday, April 21st at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / April 19, 2021 / Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by...

Read more

Viewpoint Molecular Targeting(TM) Presents Positive Preclinical Results of VMT01 at the 10th World Congress of Melanoma

April 19, 2021 10:00 AM

-Results demonstrated that the combination of [212Pb] VMT01 and immune checkpoint inhibitors induced synergistic anti-tumor effect and 43% complete tumor responses - - Company is launching Phase 1 imaging study of VMT01 imminently with provisional results expected in Q4 2021, followed by Phase 1/2a therapy study for the treatment of metastatic melanoma - CORALVILLE, IA / ACCESSWIRE / April 19, 2021 / Viewpoint Molecular Targeting, Inc....

Read more

Experion Announces Q1 2021 Financial Reporting Release Date and Management Presentation

April 19, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / April 19, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash announced today that it will be reporting its 2021 first quarter financial results for the period ending February 28, 2021 after market close on Wednesday April 28,...

Read more

Biotech Medics, Inc. Now Operating Sumcoin Nodes Directly

April 16, 2021 6:35 PM

WOODLAND HILLS, CA / ACCESSWIRE / April 16, 2021 / BioTech Medics, Inc. (OTC PINK:BMCS) Announces the firm has begun operating Sumcoin Nodes directly and is exploring how to support the network with mining equipment. A significant step while BMCS continues to cooperate with FINRA for the Company's name change approval from Bio Tech Medics to BMCS Sumcoin Index Fund Inc. According to Anthony K. Miller, CEO, "We want utilize the Sumcoin Network...

Read more

Experion to Webcast Live at VirtualInvestorConferences.com on April 20, 2021

April 16, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / April 16, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) announced today that CEO, Mr. Jarrett Malnarich will present live at VirtualInvestorConferences.com on April 20, 2021 at 3:30 PM EST / 12:30 PM PST. Experion invites shareholders, investors, advisors, and analysts to attend the real-time, interactive investor presentation. This will be a live, online event...

Read more

Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX)

April 16, 2021 8:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / April 16, 2021 / Stella Diagnostics, Inc. (OTC PINK:JMDP) ("Stella" or "The Company") announced today that its corporate name change from "JMP Properties, Inc." to "Stella Diagnostics, Inc." became effective on April 16, 2021. In connection with the name change, the Company's common stock will begin trading on the OTC Markets under the ticker symbol "SLDX" at the open of market trading on April 16,...

Read more

Lexaria Appoints New Chief Financial Officer and Issues Consultant Warrants

April 15, 2021 4:05 PM

KELOWNA, BC / ACCESSWIRE / April 15, 2021 / Lexaria Bioscience Corp. (Nasdaq:LEXX)(Nasdaq:LEXXW)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces the appointment of a new Chief Financial Officer and the issuance of share purchase warrants to third party consultants. Lexaria is pleased to announce that effective April 15, 2021, Gregory Downey will be assuming the role of Chief Financial Officer of...

Read more

MJ Biotech Inc. Ships Its First Purchase Order to Namibia Africa

April 15, 2021 7:30 AM

CHEYENNE, WY / ACCESSWIRE / April 15, 2021 / MJ Biotech Inc. (OTC PINK:MJTV), has shipped its first Purchase Order of its COVID 19 Rapid Test Kit to Namibia, Africa. The Rapid Test Kit is a nasal swab test that produces test results in 10 minutes. This purchase order of 120 units is designed to facilitate an efficient method of delivery as the Purchase Orders increase in order quantity. This is an exciting time for the Company and for Invest...

Read more

Tetra Bio-Pharma Announces Granting of U.S. Patent for Treatment of Interstitial Cystitis

April 15, 2021 2:00 AM

Tetra strengthens its intellectual property portfolio Approximately 12% of women may have early symptoms of Interstitial Cystitis OTTAWA, ON / ACCESSWIRE / April 15, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a biopharmaceutical pioneer in immunomodulator drug discovery and development announces the granting of a new patent from the United States Patent and Trademark Office for patent...

Read more

Medspresso(TM) Partners with CNC Products for Online Listing and CSR Activities

April 14, 2021 11:15 AM

CAPE TOWN, SA / ACCESSWIRE / April 14, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan" or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: The company is pleased to announce its brand Medspresso™ has partnered with CNC, the preferred food supplier to top chefs, restaurants, and home cooks all across South Africa. CNC's...

Read more

BioLargo Inc. to Present at Benzinga Cleantech Small Cap Conference on April 22nd at 11:20am EST

April 14, 2021 8:30 AM

WESTMINSTER, CA / ACCESSWIRE / April 14, 2021 / BioLargo, Inc. (OTCQB:BLGO), developer of sustainable clean technologies and a full-service environmental engineering company will be presenting at the Benzinga Cleantech Small Cap Conference on Earth Day, April 22, 2021, at 11:20am EST. The company invites its shareholders and all interested parties to learn more about BioLargo, cleantech, and environmental remediation investment...

Read more